Tivicay (dolutegravir)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 USE IN SPECIFIC POPULATIONS Pediatric Patients The safety, virologic, and immunologic responses in subjects who...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts